CureLeads

🌙 Ramadan Mubarak from CureLeads!🌙 As the holy month of Ramadan begins, we extend our warmest greetings to our employees, clients, partners, and communities around the world.  May this blessed month bring peace, joy, and prosperity to you and your loved ones. We wish everyone a fulfilling and peaceful Ramadan. 🌙 Ramadan Mubarak! 🌙 #CureLeads #RamadanMubarak #Community #Gratitude #Ramadan2025 #Peace #Blessings

We are pleased to announce our collaboration with Wellesta, our strategic partner, for commercialization of VECanDx ELISA test in Lebanon, Iraq & Egypt markets for early detection of bladder cancer. This strategic advancement aims to bring this non-invasive, affordable, and highly efficient product for early detection and better management of bladder cancer treatment in Hematuria patients and high-risk individuals, for enhanced patient outcomes.    Mohamad Rammal, CEO of CureLeads, shared his enthusiasm, stating, "We are excited to bring the VECanDx ELISA bladder cancer detection kit to Lebanon, Iraq, and Egypt. This collaboration with Wellesta reflects our shared commitment to introducing affordable, non-invasive technologies that play a vital role in the early detection of bladder cancer, enabling efficient patient treatment across the region."   Milan Paleja, Chairman & Managing Director of Wellesta, added, "With CureLeads as our strategic partner in MENA, we are confident to enhance clinical practices for bladder cancer screening for efficient treatment. Through the commercialization of this innovative and cost-effective technology, we aim to significantly improve patient outcomes in these regions." https://lnkd.in/dN8bYSuR https://lnkd.in/dMYAXp7t https://lnkd.in/dZes9pDB https://lnkd.in/dwZuPSUp   #Cureleads #Wellesta #BladderCancer #EarlyDetection #Healthcare #Innovation

🎉 Happy New Year 2025 from CureLeads! 🎉 As we reflect on the successes, challenges, and milestones of 2024, we want to express our deepest gratitude to our incredible team, clients, partners, and stakeholders who made this journey possible. 🙏 The past year has been filled with growth, collaboration, and innovation. We’re proud of the strides we've made together and are excited for the opportunities the new year holds. In 2025, we’re committed to continuing to deliver excellence, fostering stronger relationships, and creating more impactful solutions. Here’s to new beginnings, continued success, and endless possibilities in 2025! 🚀 Thank you for being a part of our journey – we look forward to achieving even more together this year! #CURELEADS #HappyNewYear #NewYear2025 #Gratitude #Innovation #Success #Teamwork #Growth #FutureFocused

CureLeads is partnering with the Lebanese Urology Society to raise awareness about the Prostate Cancer early diagnosis. الفحص المبكر لسرطان البروستات ضروري وهو عبارة عن فحص دم وفحص سريري !!! #CURELEADS #ProstateAwareness #MenHealthMonth #VisitYourUrologist #GetChecked #LebaneseUrologySociety #Movember

CureLeads, a leading MENA BioPharma company and ANSEA a global healthcare consulting firm, have formed a strategic partnership. CureLeads, will enable ANSEA’s healthcare consulting services across the MENA region, leveraging its strong regional presence and stakeholder relationships. Mohamad Rammal, CureLeads, CEO, said, "Our partnership will bring innovative therapies and global best practices to drive patient access faster." ''With CureLeads, deep understanding of MENA healthcare systems that are rapidly evolving into value-based assessment, ANSEA can expand its services in this fast-evolving market," added Anand Jha, ANSEA Founder and Managing Director. #partnership #healthcare #MENA #patientaccess #growth

We are proud to announce that Cureleads, in collaboration with Pharmaline and our strategic partner Wellesta, has successfully launched Estaporin®️, in Lebanon, the first generic Cyclosporin eyedrops using cutting-edge Micellar Nano Particle (MNP) technology from SGN Nanopharma Inc. which significantly enhances absorption and efficacy of the product. This innovative solution marks a significant milestone in our shared mission to make quality, affordable medicine accessible to all. With this launch, we are paving the way for improved eye care, ensuring that patients receive the best treatment at a right price.

Cureleads has participated in the 6th Middle East Lung Cancer congress , held on June 21-22 at AUBMC

Cureleads is pleased to be part of the ‘Advanced therapies forum’ organized by King Faisal Specialist Hospital and Research Center. Our contribution to enhancing access of cell and gene therapies to Middle East patients is core to our mission and vision ‘Leading the Path to Cure’

Cureleads is dedicated to raising awareness about SCD by promoting early detection, ensuring timely intervention and better health outcomes

Wishing You a Joyous and Blessed Eid